Clinical Trial Update: Axatilimab With or Without Azacitidine for the Treatment of Patients With Advanced Phase Myeloproliferative Neoplasms, Myeloproliferative Neoplasm/Myelodysplastic Syndrome Overlap or High Risk Chronic Myelomonocytic Leukemia [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on Axatilimab with or without Azacitidine for advanced myeloproliferative neoplasms, including MDS/MPN overlap and high-risk CMMoL; the st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atypical Chronic Myeloid Leukemia
• Myelodysplastic Myeloproliferative Neoplasm
• Myelomonocytic Leukemia

Drugs mentioned

• AZACITIDINE (AZACITIDINE)
• Axatilimab (axatilimab)

Snippet

Sponsor: Uma Borate | Conditions: Atypical Chronic Myeloid Leukemia, Chronic Myelomonocytic Leukemia | Phase 1, Phase 2 | Status: RECRUITING